top of page


STADA and SBP Group partner on Keytruda biosimilar and up to three additional biosimilar programmes
STADA and SBP Group have launched a strategic biosimilars partnership beginning with a proposed Keytruda biosimilar and providing a framework for up to three additional programmes.

nuaxia
Sep 292 min read


UK government and CSL Seqirus expand vaccine partnership with first planned AUJEMFLU rollout
The UK government and CSL Seqirus have expanded their vaccine partnership, including plans for the UK to become the first country to introduce AUJEMFLU from the 2027/28 influenza season.

nuaxia
Sep 232 min read


Ori Biotech signs 10-year $120m cell-therapy manufacturing partnership
Ori Biotech has entered a 10-year commercial partnership worth up to $120 million to integrate its IRO automated manufacturing platform into production of an autologous cell therapy.

nuaxia
Sep 162 min read
bottom of page